US5294630A
(en)
*
|
1992-07-07 |
1994-03-15 |
Eli Lilly And Company |
Treatment of inflammatory bowel disease
|
US5436258A
(en)
*
|
1992-09-09 |
1995-07-25 |
Eli Lilly And Company |
Prevention of bone resorption
|
EP0695742A1
(de)
|
1994-08-03 |
1996-02-07 |
Hoechst Aktiengesellschaft |
Fullerenazirin-Derivate, Verfahren zu ihrer Herstellung und deren Verwendung
|
AU703609B2
(en)
*
|
1995-04-07 |
1999-03-25 |
Teijin Limited |
Protective agent for organ or tissue
|
KR970061878A
(ko)
*
|
1996-02-23 |
1997-09-12 |
성재갑 |
신규한 아릴티아졸 유도체, 그의 제조방법 및 그를 유효성분으로 하는 제초제 조성물
|
US6472387B1
(en)
|
1996-10-07 |
2002-10-29 |
Eli Lilly And Company |
Methods of using compounds as neuro-protective agents
|
ES2199353T3
(es)
*
|
1996-10-07 |
2004-02-16 |
Eli Lilly And Company |
Nuevos compuestos utiles como agentes neuro-protectores.
|
ID21775A
(id)
*
|
1996-10-25 |
1999-07-22 |
Yoshitomi Pharmaceutical |
Senyawa-senyawa 1-fenilpirazol dan penggunaan farmasinya
|
ID24564A
(id)
|
1997-10-06 |
2000-07-27 |
Lilly Co Eli |
Senyawa-senyawa baru yang berguna sebagai bahan-bahan pelindung saraf
|
PT1956014T
(pt)
*
|
1998-06-19 |
2019-04-24 |
Teijin Pharma Ltd |
Polimorfos de ácido 2-(3-ciano-4-isobutiloxifenil)-4-metil- 5-tiazolecarboxílico e método para a sua produção
|
US6083966A
(en)
|
1998-08-31 |
2000-07-04 |
University Of Florida |
Thiazoline acid derivatives
|
NZ526880A
(en)
|
1998-09-21 |
2005-05-27 |
Univ Florida |
Antimalarial agents
|
US6410562B1
(en)
|
1998-12-18 |
2002-06-25 |
Eli Lilly And Company |
Hypoglycemic imidazoline compounds
|
US6528652B1
(en)
|
1999-01-21 |
2003-03-04 |
Chronimed |
Composition and device for detecting leukocytes in urine
|
US6348324B1
(en)
|
1999-01-21 |
2002-02-19 |
Hypoguard America Limited |
Composition and device for detecting leukocytes in urine
|
EP2329842A3
(en)
*
|
2000-05-12 |
2011-07-27 |
Immunex Corporation |
Interleukin-1 inhibitors in the treatment of diseases
|
DE10106852A1
(de)
|
2001-02-14 |
2002-09-05 |
T Luger |
Entzündungshemmende Verbindungen
|
JP4917243B2
(ja)
*
|
2001-05-23 |
2012-04-18 |
日本曹達株式会社 |
チアゾール化合物の製造方法
|
SI1488790T1
(sl)
*
|
2002-03-28 |
2014-09-30 |
Teijin Pharma Limited |
Trden pripravek, ki vsebuje eno samo kristalno a-obliko derivata tiazolkarboksilne kisline
|
US7273866B2
(en)
*
|
2002-12-20 |
2007-09-25 |
Bristol-Myers Squibb Company |
2-aryl thiazole derivatives as KCNQ modulators
|
US20040122067A1
(en)
*
|
2002-12-20 |
2004-06-24 |
Lin Zhao |
Treatment of chronic heart failure
|
US6933308B2
(en)
*
|
2002-12-20 |
2005-08-23 |
Bristol-Myers Squibb Company |
Aminoalkyl thiazole derivatives as KCNQ modulators
|
JP4532408B2
(ja)
|
2003-03-13 |
2010-08-25 |
田辺三菱製薬株式会社 |
腫瘍形成抑制剤
|
US20050027128A1
(en)
*
|
2003-07-30 |
2005-02-03 |
Robbins Timothy A. |
Substituted thiazoles
|
AU2003270473A1
(en)
|
2003-09-09 |
2005-04-27 |
University Of Florida |
Desferrithiocin derivatives and their use as iron chelators
|
US7037927B2
(en)
|
2003-10-16 |
2006-05-02 |
Abbott Laboratories |
Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor
|
US7485657B2
(en)
*
|
2004-05-12 |
2009-02-03 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Anti-cytokine heterocyclic compounds
|
EP1757610B1
(en)
*
|
2004-06-14 |
2011-06-08 |
Nippon Chemiphar Co., Ltd. |
Condensed pyrimidine derivative and xanthine oxidase inhibitor
|
KR20070045272A
(ko)
*
|
2004-08-27 |
2007-05-02 |
아스텔라스세이야쿠 가부시키가이샤 |
2-페닐피리딘 유도체
|
US7612108B2
(en)
|
2004-08-27 |
2009-11-03 |
Astellas Pharma Inc. |
2-phenylthiophene derivative
|
EP1799207A2
(en)
*
|
2004-10-13 |
2007-06-27 |
PTC Therapeutics, Inc. |
Pyrazole or triazole compounds and their use for the manufacture of a medicament for treating somatic mutation-related diseases
|
AU2006228690A1
(en)
*
|
2005-03-31 |
2006-10-05 |
Ucb Pharma S.A. |
Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses
|
TR201910900T4
(tr)
|
2005-04-04 |
2019-08-21 |
Univ Florida |
Desferritiyokin polieter analogları.
|
EP1883405A4
(en)
|
2005-05-09 |
2010-01-27 |
Takeda Pharmaceuticals North A |
METHODS OF TREATING NEPHROLITHIASIS
|
JP2009501721A
(ja)
*
|
2005-07-12 |
2009-01-22 |
アカディア ファーマシューティカルズ インコーポレイテッド |
レチノイン酸受容体における活性を伴う化合物
|
WO2007019153A2
(en)
*
|
2005-08-03 |
2007-02-15 |
Tap Pharmaceutical Products, Inc. |
Methods for treating hypertension
|
CA2623327A1
(en)
*
|
2005-10-07 |
2007-04-19 |
Kissei Pharmaceutical Co., Ltd. |
Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
|
KR20080051157A
(ko)
*
|
2005-10-07 |
2008-06-10 |
아스텔라스세이야쿠 가부시키가이샤 |
트리아릴카르복시산 유도체
|
CN1954814A
(zh)
*
|
2005-10-26 |
2007-05-02 |
重庆医药工业研究院有限责任公司 |
一种具有协同作用治疗痛风的药物组合物及其制备方法
|
CN100430055C
(zh)
*
|
2005-11-11 |
2008-11-05 |
天津泰普药品科技发展有限公司 |
2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑甲酸和聚乙烯吡咯烷酮玻璃态固溶体及其制备方法
|
EP1992361B1
(en)
|
2006-02-24 |
2012-05-02 |
Astellas Pharma Inc. |
Remedy or preventive for digestive ulcer
|
US8653115B2
(en)
*
|
2006-06-13 |
2014-02-18 |
Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences |
Heterocyclic non-nucleoside compounds, their preparation, pharmaceutical composition and their use as antiviral agents
|
CA2658342A1
(en)
*
|
2006-07-19 |
2008-01-24 |
Nippon Medical School Foundation |
Therapeutic agent for amyotrophic lateral sclerosis
|
CN101139325B
(zh)
*
|
2006-09-07 |
2010-05-12 |
上海医药工业研究院 |
2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑甲酸晶型及其制备方法
|
CN101812035B
(zh)
*
|
2006-09-07 |
2012-03-21 |
上海医药工业研究院 |
2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑甲酸晶型及其制备方法
|
US20090124623A1
(en)
*
|
2006-11-13 |
2009-05-14 |
Christopher Lademacher |
Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors
|
BRPI0718611A2
(pt)
*
|
2006-11-13 |
2014-02-25 |
Takeda Pharmaceuticals North America Inc |
Métodos para preservar a função renal utilizando inibidores da xantina oxidoredutase.
|
CN102093309B
(zh)
*
|
2006-12-07 |
2012-07-04 |
重庆医药工业研究院有限责任公司 |
非布司他的晶型及其制备方法
|
CN102093308B
(zh)
*
|
2006-12-07 |
2012-08-29 |
重庆医药工业研究院有限责任公司 |
非布司他的晶型及其制备方法
|
CN1970547B
(zh)
*
|
2006-12-07 |
2011-04-06 |
重庆医药工业研究院有限责任公司 |
非布司他的晶型及其制备方法
|
WO2008089296A1
(en)
*
|
2007-01-19 |
2008-07-24 |
Takeda Pharmaceuticals North America |
Methods for preventing or reducing the number of gout flares using xanthine oxidoreductase inhibitors and anti-inflammatory agents
|
WO2008115433A1
(en)
|
2007-03-15 |
2008-09-25 |
University Of Florida |
Desferrithiocin polyether analogues
|
WO2008126772A1
(ja)
*
|
2007-04-05 |
2008-10-23 |
Astellas Pharma Inc. |
高血圧治療剤
|
PL2184989T3
(pl)
|
2007-08-13 |
2015-10-30 |
Monsanto Technology Llc |
Kompozycje i sposoby zwalczania nicieni
|
US8263622B2
(en)
*
|
2008-10-15 |
2012-09-11 |
Kissei Pharmaceutical Co., Ltd. |
Fused-ring derivative and medical application of same
|
WO2010044410A1
(ja)
*
|
2008-10-15 |
2010-04-22 |
キッセイ薬品工業株式会社 |
ビアリールイソニコチン酸誘導体及びその医薬用途
|
CN101759656B
(zh)
*
|
2008-12-12 |
2013-04-03 |
重庆医药工业研究院有限责任公司 |
非布司他新晶型及其制备方法
|
CN101768150B
(zh)
*
|
2009-01-05 |
2014-08-06 |
常州市第四制药厂有限公司 |
2-[3-氰基-4-异丁氧基苯基]-4-甲基噻唑-5-甲酸晶型及其制备方法
|
CN101781270B
(zh)
*
|
2009-01-20 |
2013-03-27 |
重庆医药工业研究院有限责任公司 |
一种高纯度的非布司他及其制备方法
|
US20100311756A1
(en)
*
|
2009-01-22 |
2010-12-09 |
Takeda Pharmaceuticals North America, Inc. |
Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof
|
CN101475541B
(zh)
*
|
2009-02-09 |
2011-05-25 |
扬州哈泰克材料有限公司 |
4-甲基噻唑-5-羧酸的一种制备方法
|
US8952174B2
(en)
|
2009-02-27 |
2015-02-10 |
Teijin Pharma Limited |
Process for producing phenyl-substituted heterocyclic derivative through coupling using transition metal catalyst
|
CN101580495A
(zh)
*
|
2009-05-25 |
2009-11-18 |
沈阳药科大学 |
5-取代苯基-3-异噁唑甲酸及其酯类化合物、组合物及其制备方法
|
WO2010143735A1
(ja)
|
2009-06-09 |
2010-12-16 |
帝人ファーマ株式会社 |
4-置換ベンゾチオアミド誘導体の製造法
|
CN102803240A
(zh)
|
2009-06-10 |
2012-11-28 |
特瓦制药工业有限公司 |
非布索坦的晶形
|
EP2266966A1
(en)
|
2009-06-11 |
2010-12-29 |
Chemo Ibérica, S.A. |
A process for the preparation of febuxostat
|
CN101928259B
(zh)
*
|
2009-06-18 |
2012-10-03 |
南京海辰药业有限公司 |
2-芳基噻唑衍生物及其药物组合物
|
EP2446885B1
(en)
|
2009-06-26 |
2017-09-06 |
Teijin Pharma Limited |
Therapeutic agent for hypertension or normal high blood pressure
|
CN103936689B
(zh)
*
|
2009-07-17 |
2016-08-17 |
北京利乐生制药科技有限公司 |
2-[3-氰基-4-异丁氧基苯基]-4-甲基噻唑-5-甲酸晶型及其制备方法
|
EP2483256A1
(en)
|
2009-09-10 |
2012-08-08 |
Teva Pharmaceutical Industries Ltd. |
Processes for preparing febuxostat
|
IT1395936B1
(it)
*
|
2009-09-29 |
2012-11-02 |
Dipharma Francis Srl |
Sali di febuxostat
|
TWI423962B
(zh)
|
2009-10-07 |
2014-01-21 |
Lg Life Sciences Ltd |
有效作為黃嘌呤氧化酶抑制劑之新穎化合物、其製備方法及含該化合物之醫藥組成物
|
WO2011073617A1
(en)
|
2009-12-14 |
2011-06-23 |
Cipla Limited |
Processes for the preparation of febuxostat and salts thereof
|
WO2011080651A2
(en)
|
2009-12-31 |
2011-07-07 |
Ranbaxy Laboratories Limited |
Polymorphic forms of febuxostat
|
US20130190366A1
(en)
|
2010-02-19 |
2013-07-25 |
Cadila Healthcare Limited |
Substantially pure salts of febuxostat and processes for preparation thereof
|
CA2788437A1
(en)
*
|
2010-02-19 |
2011-08-25 |
Takeda Pharmaceuticals U.S.A., Inc. |
Methods for stabilizing joint damage in subjects using xanthine oxidoreductase inhibitors
|
EP2542540A1
(en)
|
2010-03-04 |
2013-01-09 |
Ranbaxy Laboratories Limited |
Polymorph of 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid
|
WO2011139886A2
(en)
|
2010-04-29 |
2011-11-10 |
Dr. Reddy's Laboratories Ltd. |
Preparation of febuxostat
|
IT1400609B1
(it)
|
2010-05-10 |
2013-06-14 |
Menarini Int Operations Lu Sa |
Associazione di inibitori della xantina ossidasi e metformina e loro uso.
|
IT1400309B1
(it)
|
2010-05-10 |
2013-05-24 |
Menarini Int Operations Lu Sa |
Associazione di inibitori della xantina ossidasi e calcio antagonisti e loro uso.
|
IT1400310B1
(it)
|
2010-05-10 |
2013-05-24 |
Menarini Int Operations Lu Sa |
Associazione di inibitori della xantina ossidasi e statine e loro uso.
|
IT1400311B1
(it)
|
2010-05-10 |
2013-05-24 |
Menarini Int Operations Lu Sa |
Associazione di inibitori della xantina ossidasi e antagonisti del recettore dell'angiotensina ii e loro uso.
|
AR081930A1
(es)
|
2010-06-16 |
2012-10-31 |
Ardea Biosciences Inc |
Compuestos de tioacetato
|
SG186301A1
(en)
|
2010-06-16 |
2013-02-28 |
Takeda Pharmaceuticals Usa Inc |
Novel modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors
|
JP5709146B2
(ja)
|
2010-06-16 |
2015-04-30 |
アルデア バイオサイエンシーズ インク. |
フェニルチオ酢酸化合物、組成物、および、その使用方法
|
BR112012032543A2
(pt)
|
2010-06-25 |
2016-11-22 |
Teijin Pharma Ltd |
composição farmacêutica de liberação prolongada, e, método para tratamento ou preveção de condição
|
AR081267A1
(es)
*
|
2010-07-13 |
2012-07-18 |
Interquim Sa |
Procedimiento de obtencion de la forma cristalina a del febuxostat
|
AU2011284400B2
(en)
*
|
2010-07-30 |
2013-11-07 |
Sun Pharmaceutical Industries Limited |
Improved process for the preparation of febuxostat
|
WO2012020272A2
(en)
|
2010-08-13 |
2012-02-16 |
EGIS GYÓGYSZERGYÁR Nyilvánosan Müködö Részvénytársaság |
New salts, polymorphs and solvates of a pharmaceutical active ingredient
|
US8916714B2
(en)
|
2010-08-27 |
2014-12-23 |
Teijin Pharma Limited |
Method for producing phenyl-substituted heterocyclic derivative by means of coupling method using palladium compound
|
WO2012032528A2
(en)
|
2010-09-08 |
2012-03-15 |
Natco Pharma Limited |
Improved process to prepare ethyl 4-methyl-2-(4-(2-methylpropyloxy)-3-cyanophenyl)-5-thiazolecarboxylate
|
CN103298466B
(zh)
|
2010-09-10 |
2015-11-25 |
武田制药美国有限公司 |
茶碱和非布索坦的联合治疗方法
|
US20130303780A1
(en)
|
2010-11-08 |
2013-11-14 |
Siva Rama Prasad Vellanki |
Process for the preparation of 2-arylthiazole derivatives
|
WO2012073259A1
(en)
|
2010-12-02 |
2012-06-07 |
Indoco Remedies Limited |
Novel process for the preparation of febuxostat
|
WO2012098501A1
(en)
|
2011-01-21 |
2012-07-26 |
Ranbaxy Laboratories Limited |
Febuxostat co-crystals
|
WO2012109573A1
(en)
*
|
2011-02-11 |
2012-08-16 |
Purdue Research Foundation |
Substituted thiazoles for use as antiviral agents
|
CN102643249A
(zh)
*
|
2011-02-18 |
2012-08-22 |
苏州波锐生物医药科技有限公司 |
2-芳基噻唑衍生物,其可药用盐及用途
|
WO2012131590A1
(en)
|
2011-03-31 |
2012-10-04 |
Sandoz Ag |
An improved process for preparation of febuxostat and its polymorphic crystalline form c thereof
|
WO2012140632A1
(en)
|
2011-04-15 |
2012-10-18 |
Ranbaxy Laboratories Limited |
Febuxostat solid dispersion
|
WO2012153313A1
(en)
|
2011-05-11 |
2012-11-15 |
Ranbaxy Laboratories Limited |
Pharmaceutical composition of febuxostat
|
WO2012172461A1
(en)
|
2011-06-13 |
2012-12-20 |
Ranbaxy Laboratories Limited |
Pharmaceutical compositions of febuxostat
|
US20140228417A1
(en)
*
|
2011-10-05 |
2014-08-14 |
Mapi Pharma Ltd. |
Process and intermediates for the preparation of substituted 2-arylthiazole carboxylic acids
|
TW201328692A
(zh)
|
2011-10-11 |
2013-07-16 |
Univ Osaka |
脫髓鞘疾病之治療劑及預防劑
|
CN106963761A
(zh)
|
2011-11-03 |
2017-07-21 |
阿迪亚生命科学公司 |
3,4‑二取代的吡啶化合物、其使用方法以及包含该化合物的组合物
|
JP2014533297A
(ja)
*
|
2011-11-15 |
2014-12-11 |
マイラン ラボラトリーズ リミテッドMylan Laboratories Limited |
フェブキソスタットの多形の調製方法
|
EP2790697B1
(en)
|
2011-12-16 |
2019-10-23 |
University of Florida Research Foundation, Inc. |
Uses of 4'-desferrithiocin analogs
|
WO2013088449A1
(en)
|
2011-12-16 |
2013-06-20 |
Natco Pharma Limited |
Stable crystal form of febuxostat and process for the preparation thereof
|
EP2606888A1
(en)
*
|
2011-12-19 |
2013-06-26 |
Dompe' S.P.A. |
Trpm8 antagonists
|
ES2676884T3
(es)
*
|
2011-12-19 |
2018-07-25 |
Dompé Farmaceutici S.P.A. |
Antagonistas de TRPM8
|
KR20140134266A
(ko)
*
|
2012-01-27 |
2014-11-21 |
데이진 화-마 가부시키가이샤 |
당뇨병의 치료약
|
EP2925306A1
(en)
|
2012-07-12 |
2015-10-07 |
Alembic Pharmaceuticals Limited |
Pharmaceutical composition of febuxostat
|
EP2692342A1
(en)
|
2012-07-30 |
2014-02-05 |
Interquim, S.A. |
Process for the preparation of pharmaceutical compositions comprising febuxostat in the form of tablets
|
CN103130744B
(zh)
*
|
2012-08-28 |
2014-10-15 |
沈阳药科大学 |
一种硒唑甲酸类化合物及其制备方法和用途
|
WO2014057461A1
(en)
|
2012-10-11 |
2014-04-17 |
Ranbaxy Laboratories Limited |
Process for the preparation of crystalline form g of febuxostat
|
JP5907396B2
(ja)
*
|
2012-10-23 |
2016-04-26 |
国立大学法人福井大学 |
腫瘍融解症候群の治療薬及び予防薬
|
CN103848798B
(zh)
*
|
2012-11-30 |
2016-01-06 |
镇江新元素医药科技有限公司 |
2-芳基硒唑化合物及其药物组合物
|
US8883857B2
(en)
|
2012-12-07 |
2014-11-11 |
Baylor College Of Medicine |
Small molecule xanthine oxidase inhibitors and methods of use
|
CN103936693B
(zh)
*
|
2013-01-22 |
2016-06-15 |
沈阳药科大学 |
2-(3-氰基-4-取代苯基)-4-甲基-1,3-硒唑-5-甲酸及其酯类化合物和制备方法
|
TWI606048B
(zh)
*
|
2013-01-31 |
2017-11-21 |
帝人製藥股份有限公司 |
唑苯衍生物
|
CN103333134B
(zh)
*
|
2013-03-01 |
2016-02-24 |
沈阳药科大学 |
2-(3-氰基-4-烷氧基)苯基-4-取代噻唑-5-甲酸类化合物、组合物及其制备方法和用途
|
CN104163782A
(zh)
*
|
2013-05-17 |
2014-11-26 |
重庆圣华曦药业股份有限公司 |
一种制备3,4-取代的硫代苯甲酰胺的方法及其在非布司他合成中的应用
|
WO2014192977A1
(ja)
*
|
2013-05-31 |
2014-12-04 |
帝人ファーマ株式会社 |
チアゾール誘導体
|
CN105452228B
(zh)
|
2013-08-07 |
2018-10-09 |
法尔玛赞公司 |
制备非布索坦的新颖方法
|
CN104418822B
(zh)
*
|
2013-08-22 |
2016-12-28 |
南京华威医药科技开发有限公司 |
具有黄嘌呤氧化酶抑制活性的化合物及其用途
|
CN103524456B
(zh)
*
|
2013-09-30 |
2016-06-01 |
南京华威医药科技开发有限公司 |
一种硒唑甲酸类化合物及其盐
|
AU2014352780A1
(en)
|
2013-11-22 |
2016-06-09 |
University Of Florida Research Foundation, Inc. |
Desferrithiocin analogs and uses thereof
|
EP2881116A1
(en)
|
2013-12-05 |
2015-06-10 |
Ranbaxy Laboratories Limited |
Febuxostat composition
|
CA2948792A1
(en)
*
|
2014-05-13 |
2015-11-19 |
Teijin Pharma Limited |
Novel crystalline polymorphs of pyridine derivative and method for producing the same
|
DK3157918T3
(da)
*
|
2014-06-23 |
2019-05-13 |
Dompe Farm Spa |
2-aryl-4-hydroxy-1,3-thiazolderivater anvendelige som trpm8-inhibitorer i behandling af neuralgi, smerte, copd og astma
|
CA2955577A1
(en)
|
2014-07-30 |
2016-02-04 |
Teijin Pharma Limited |
Xanthine oxidase inhibitor
|
NZ729068A
(en)
|
2014-07-30 |
2022-05-27 |
Teijin Pharma Ltd |
Azole benzene derivative and crystal thereof
|
BR112017001659A2
(ja)
|
2014-07-30 |
2018-01-30 |
Teijin Pharma Limited |
A crystal of a Azole benzene induction object
|
JP2017165653A
(ja)
*
|
2014-07-30 |
2017-09-21 |
帝人ファーマ株式会社 |
アゾールカルボン酸誘導体
|
CZ27857U1
(cs)
|
2014-12-12 |
2015-02-23 |
Zentiva, K.S. |
Formulace obsahující tuhý roztok febuxostatu
|
CN107427517B
(zh)
|
2015-02-24 |
2021-11-16 |
国立大学法人鸟取大学 |
用于痴呆症的预防及/或治疗的医药
|
WO2016160706A1
(en)
*
|
2015-03-28 |
2016-10-06 |
Wisconsin Alumni Research Foundation |
Inhibitors of collagen prolyl 4-hydroxylase
|
CN107708693A
(zh)
|
2015-04-27 |
2018-02-16 |
佛罗里达大学研究基金会 |
代谢程序化的金属螯合剂及其用途
|
EP3344604B1
(en)
*
|
2015-09-02 |
2020-11-04 |
Sunshine Lake Pharma Co., Ltd. |
Carboxy substituted (hetero) aromatic ring derivatives and preparation method and uses thereof
|
EP3417858B8
(en)
|
2016-02-19 |
2020-12-30 |
National University Corporation Tottori University |
Therapeutic or prophylactic drug for dementia
|
CN106146419A
(zh)
*
|
2016-08-01 |
2016-11-23 |
沈阳药科大学 |
黄嘌呤氧化酶抑制剂
|
CN108358866B
(zh)
*
|
2017-01-12 |
2021-03-23 |
江西同和药业股份有限公司 |
一种非布司他中间体的制备方法及其在制备非布司他中的应用
|
CN110066258A
(zh)
*
|
2018-01-23 |
2019-07-30 |
湘北威尔曼制药股份有限公司 |
噻唑-5-甲酸衍生物及其制备方法与应用
|
CN108484494B
(zh)
*
|
2018-06-15 |
2021-07-30 |
沈阳药科大学 |
2-氧代-1,2-二氢吡啶-4-甲酸类化合物
|
CN109810073B
(zh)
*
|
2019-02-28 |
2023-01-06 |
南京海辰药业股份有限公司 |
4-芳基噻唑衍生物及其药物组合物
|
WO2021033773A1
(ja)
|
2019-08-21 |
2021-02-25 |
国立大学法人東京大学 |
Abcc11阻害剤
|
CN113024534B
(zh)
*
|
2019-12-24 |
2023-03-21 |
武汉光谷亚太医药研究院有限公司 |
2-吡啶基噻唑衍生物及其应用
|
CN115572272B
(zh)
*
|
2022-11-15 |
2024-05-07 |
湖北华世通生物医药科技有限公司 |
非布司他及其醛基酯类中间体的制备方法
|